Zefcort 30mg Tablet contains Deflazacort, a corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including but not limited to rheumatoid arthritis, systemic lupus erythematosus, and certain allergic disorders. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing inflammation through inhibition of multiple inflammatory cytokines and mediators. The 30mg dosage is typically prescribed based on the severity of the condition and patient response, with careful titration to minimize potential adverse effects. Zefcort is also utilized in the treatment of Duchenne muscular dystrophy to improve muscle strength and function. Patients should adhere strictly to the prescribed regimen, as abrupt discontinuation may precipitate adrenal insufficiency. Common side effects may include gastrointestinal disturbances, increased susceptibility to infections, hyperglycemia, and mood alterations. Regular monitoring of blood pressure, blood glucose, and bone density is recommended during prolonged therapy. Contraindications include systemic fungal infections and known hypersensitivity to Deflazacort or any of its excipients. Use during pregnancy and lactation should be under strict medical supervision. Zefcort 30mg Tablet should be stored in a cool, dry place away from direct sunlight and out of reach of children.